Magalie Rocheville

7TM pharmacology measured by label-free: a holistic approach to cell signalling.

J. Jerman, M. Rocheville, Magalie Rocheville, 2009, Current opinion in pharmacology.

Subtypes of the Somatostatin Receptor Assemble as Functional Homo- and Heterodimers*

U. Kumar, U Kumar, R Sasi, 2000, The Journal of Biological Chemistry.

Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity.

U. Kumar, U Kumar, Y C Patel, 2000, Science.

The Cytoplasmic Tail of the Human Somatostatin Receptor Type 5 Is Crucial for Interaction with Adenylyl Cyclase and in Mediating Desensitization and Internalization*

U. Kumar, Y. Patel, M. Rocheville, 1998, The Journal of Biological Chemistry.

Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells

Enrico Gratton, Don C Lamb, Ramesh C. Patel, 2002, Proceedings of the National Academy of Sciences of the United States of America.

The identification of structurally novel, selective, orally bioavailable positive modulators of mGluR2.

Paul W Smith, Emma L. Koppe, C. Corti, 2010, Bioorganic & medicinal chemistry letters.

In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE)

A. Capelli, M. Corsi, L. Gordon, 2011, Neuropharmacology.

An industrial perspective on positive allosteric modulation as a means to discover safe and selective drugs.

S. Garland, M. Rocheville, Magalie Rocheville, 2010, Drug discovery today. Technologies.

Evaluation of the mGlu8 receptor as a putative therapeutic target in schizophrenia

Paul R. Murdock, P. Maycox, J. Kew, 2007, Brain Research.